» Articles » PMID: 2017198

Biodegradable Microspheres As a Vaccine Delivery System

Overview
Journal Mol Immunol
Date 1991 Mar 1
PMID 2017198
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The utility of biodegradable and biocompatible microspheres as a vaccine delivery system for the induction of systemic and disseminated mucosal antibody responses was investigated. Intraperitoneal (ip) injection into mice of 1-10 microns microspheres, constructed of the copolymer poly(DL-lactide-coglycolide) (DL-PLG) which contained approximately 1% by weight a formalinized toxoid vaccine of staphylococcal enterotoxin B (SEB), dramatically potentiated the circulating IgG anti-toxin antibody response as compared to the free toxoid. The initiation of vaccine release was delayed in larger microspheres, and a mixture of 1-10 and 20-50 microns microspheres stimulated both a primary and an anamnestic secondary anti-toxin response following a single injection. However, neither free nor microencapsulated SEB toxoid induced a detectable mucosal IgA anti-toxin response following systemic injection. In contrast, three peroral immunizations with toxoid-microspheres stimulated circulating IgM, IgG and IgA anti-toxin antibodies and a concurrent mucosal IgA response in saliva, gut washings and lung washings. Systemic immunization with microencapsulated toxoid primed for the induction of disseminated mucosal IgA responses by subsequent oral or intratracheal (it) boosting in microspheres, while soluble toxoid was ineffective at boosting. These results indicate that biodegradable and biocompatible microspheres represent an adjuvant system with potentially widespread application in the induction of both circulating and mucosal immunity.

Citing Articles

Is Lactococcus lactis a Suitable Candidate for Use as a Vaccine Delivery System Against Helicobacter pylori?.

Haghighi F, Farsiani H Curr Microbiol. 2024; 82(1):30.

PMID: 39643816 DOI: 10.1007/s00284-024-03994-1.


Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Coffey J, Gaiha G, Traverso G Annu Rev Pharmacol Toxicol. 2020; 61:517-540.

PMID: 32466690 PMC: 8057107. DOI: 10.1146/annurev-pharmtox-030320-092348.


Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.

Zhang L, Yang W, Hu C, Wang Q, Wu Y Int J Nanomedicine. 2018; 13:2973-2987.

PMID: 29861631 PMC: 5968786. DOI: 10.2147/IJN.S154743.


Automated Gravimetric Calibration to Optimize the Accuracy and Precision of TECAN Freedom EVO Liquid Handler.

Bessemans L, Jully V, de Raikem C, Albanese M, Moniotte N, Silversmet P J Lab Autom. 2016; 21(5):693-705.

PMID: 26905719 PMC: 5030733. DOI: 10.1177/2211068216632349.


Alginate Microencapsulation for Oral Immunisation of Finfish: Release Characteristics, Ex Vivo Intestinal Uptake and In Vivo Administration in Atlantic Salmon, Salmo salar L.

Ghosh B, Nowak B, Bridle A Mar Biotechnol (NY). 2015; 17(6):841-53.

PMID: 26410294 DOI: 10.1007/s10126-015-9663-7.